Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

1.2K
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
1.2K
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

467
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
467
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

41
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
41
Clearance Models: Noncompartmental Models01:17

Clearance Models: Noncompartmental Models

325
Clearance is a pharmacokinetic parameter traditionally defined by compartment models, signifying the rate at which a drug is expelled from the body. However, a noncompartmental model offers an alternative method for assessing clearance, primarily employing empirical data obtained after administering a single drug dose.
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
325
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

310
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
310
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

429
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
429

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A statistical evaluation of decision-making methods and the efficiency of Bayesian multi-arm multi-stage trials.

Clinical trials (London, England)·2026
Same author

Minimum noninferiority dose for phase I clinical trials with immunotherapy.

Biometrics·2026
Same author

Oral Nirmatrelvir-Ritonavir for Covid-19 in Higher-Risk Outpatients.

The New England journal of medicine·2026
Same author

Patient Retreat in Dose Escalation for Phase I Clinical Trials With Rare Diseases.

Statistics in medicine·2026
Same author

Wasserstein GAN-based estimation for conditional distribution function with current status data.

Lifetime data analysis·2026
Same author

Learning from the omicron BA.4/5 dominance: Strategies for future vaccination preparedness.

Vaccine·2025

Related Experiment Video

Updated: Feb 28, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

11.2K

Landmark cure rate models with time-dependent covariates.

Haolun Shi1, Guosheng Yin1

  • 1Department of Statistics and Actuarial Science, The University of Hong Kong, Lung Fu Shan, Hong Kong.

Statistical Methods in Medical Research
|June 20, 2017
PubMed
Summary
This summary is machine-generated.

This study introduces novel landmark cure rate models using time-dependent covariates for dynamic survival predictions. The method enhances predictions as new clinical data becomes available, improving patient outcome assessments.

Keywords:
Cure rate modeldynamic predictionlandmark analysisproportional hazards modelsurvival fraction

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.9K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K

Related Experiment Videos

Last Updated: Feb 28, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

11.2K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.9K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K

Area of Science:

  • Biostatistics
  • Survival Analysis
  • Clinical Research Methodology

Background:

  • Traditional survival models struggle with time-dependent patient data.
  • Estimating long-term patient outcomes requires flexible modeling approaches.
  • Cure fraction models are essential for diseases with potential long-term survivors.

Purpose of the Study:

  • To develop advanced landmark cure rate models incorporating time-dependent covariates.
  • To enable dynamic, updated survival probability predictions for patients.
  • To extend existing cure rate models for improved clinical applicability.

Main Methods:

  • Proposed a series of landmark time points for data partitioning.
  • Constructed landmark datasets comprising only at-risk individuals at each landmark time.
  • Integrated time-dependent covariates, fixed at landmark time values.
  • Extended Cox proportional hazards, accelerated failure time, and censored quantile regression models.

Main Results:

  • Simulation studies demonstrated accurate estimation of model parameters.
  • The framework effectively accommodates a cure proportion in survival data.
  • The method provides dynamic survival predictions as new information emerges.

Conclusions:

  • The proposed landmark cure rate models offer a robust framework for analyzing survival data with cure fractions and time-dependent covariates.
  • This approach facilitates more accurate and timely dynamic survival predictions in clinical settings.
  • The method was successfully illustrated using heart transplant patient data.